Design, synthesis, and biological evaluation of 2-amino-N-(2methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif inhibitors

被引：5

作者：

Zhang, Rong-Hong ^{[2
,3
]}

Wang, Shan ^{[5
,7
]}

Luo, Rong-Hua ^{[4
]}

Zhou, Meng ^{[5
,7
]}

Zhang, Hong ^{[5
,7
]}

Xu, Guo-Bo ^{[5
,7
]}

Zhao, Yong-Long ^{[5
,7
]}

Li, Yong-Jun ^{[6
,7
]}

Wang, Yong-Lin ^{[6
,7
]}

Yan, Guoyi ^{[1
]}

Liao, Shang-Gao ^{[5
,7
]}

Zheng, Yong-Tang ^{[4
]}

Li, Rui ^{[1
]}

机构：

[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China

[2] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants & Tissu, Guiyang 550004, Guizhou, Peoples R China

[3] Guizhou Med Univ, Stem Cell Res Ctr, Guiyang 550004, Guizhou, Peoples R China

[4] Chinese Acad Sci, Kunming Inst Zool,Key Lab Bioact Peptides Yunnan, Ctr Biosafety Megasci,Key Lab Anim Models & Human, KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming 650223, Yunnan, Peoples R China

[5] Guizhou Med Univ, Minist Educ, Engn Res Ctr Dev & Applicat Ethn Med & TCM, Guiyang, Guizhou, Peoples R China

[6] Guizhou Med Univ, Guizhou Prov Key Lab Pharmaceut, Guiyang, Guizhou, Peoples R China

[7] Guizhou Med Univ, Sch Pharm, Guian New Dist, Guizhou, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 24期

基金：

中国国家自然科学基金;

关键词：

Vif inhibitors; Antiviral activity; Molecular docking; Structure-activity relationship; Optimization; SMALL-MOLECULE INHIBITION; APOBEC3G; REPLICATION; RESISTANCE;

D O I：

10.1016/j.bmcl.2019.126638

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Viral infectivity factor (Vif) is one of the accessory protein of human immunodeficiency virus type I (HIV-1) that inhibits host defense factor, APOBEC3G (A3G), mediated viral cDNA hypermutations. Previous work developed a novel Vif inhibitor 2-amino-N-(2-methoxyphenyl)-6-((4-nitrophenyl)thio)benzamide (1) with strong antiviral activity. Through optimizations on the two side branches, a series of compound 1 derivatives (2-18) were designed, synthesized and tested in vitro for their antiviral activities. The biological results showed that compound 5 and 16 inhibited the virus replication efficiently with EC50 values of 9.81 and 4.62 mu M. Meanwhile, low cytotoxicities on H9 cells were observed for the generated compounds by the MTT assay. The structure-activity relationship of compound 1 was preliminarily clarified, which gave rise to the development of more potent Vif inhibitors.

引用

页数：4

共 50 条

[21] Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2? amide-derivatives: Synthesis, biological evaluation and structural studies
Ghosh, Arun K.
Shahabi, Dana
Kipfmiller, Maya
Ghosh, Ajay K.
Johnson, Megan
Wang, Yuan -Fang
Agniswamy, Johnson
Amano, Masayuki
Weber, Irene T.
Mitsuya, Hiroaki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 83
[22] Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors
Fang, Zengjun
Kang, Dongwei
Zhang, Lingzi
Huang, Boshi
Liu, Huiqing
Pannecouque, Christophe
De Clercq, Erik
Zhan, Peng
Liu, Xinyong
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (04) : 614 - 618
[23] Synthesis, molecular docking and biological evaluation of 2-(thiophen-2-yl)-1H-indoles as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
El-Hussieny, Marwa
El-Sayed, Naglaa F.
Ewies, Ewies F.
Ibrahim, Nabila M.
Mahran, Mohamed R. H.
Fouad, Marwa A.
BIOORGANIC CHEMISTRY, 2020, 95
[24] Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2′-deoxy-2′-fluoro-4′-azido nucleoside derivatives as potent anti-HBV agents
Liu, Yuan
Peng, Youmei
Lu, Jingjing
Wang, Jingwen
Ma, Haoran
Song, Chuanjun
Liu, Bingjie
Qiao, Yan
Yu, Wenquan
Wu, Jie
Chang, Junbiao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 137 - 149
[25] Design, synthesis and biological evaluation of 3-amino-6-(2-hydroxy-phenyl)pyridazin-4-aryl derivatives as SMARCA2/4 degraders
Yang, Tianqiong
Wei, Wei
Zhang, Qi
Chen, Xin
Xu, Kaiyan
Su, Xingping
Yue, Lin
Gao, Jiuyu
Wang, Ningyu
Cao, Yu
Yu, Luoting
Liu, Zhihao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 290
[26] Design, synthesis and biological evaluation of 1-hydroxy-2-phenyl-4pyridyl-1H-imidazole derivatives as xanthine oxidase inhibitors
Zhang, Tingjian
Lv, Yunying
Lei, Yu
Liu, Dan
Feng, Yao
Zhao, Jiaxing
Chen, Shaolei
Meng, Fanhao
Wang, Shaojie
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 146 : 668 - 677
[27] Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFRL858R/T790M kinase inhibitors
Ding, Shi
Dong, Xiaoyong
Gao, Ziye
Zheng, Xiangshan
Ji, Jingchao
Zhang, Mingjuan
Liu, Fang
Wu, Shuang
Li, Min
Song, Wenshan
Shen, Jiwei
Duan, Wenwen
Liu, Ju
Chen, Ye
BIOORGANIC CHEMISTRY, 2022, 118
[28] De-novo design, synthesis and evaluation of novel 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors
Subhash Chander
Penta Ashok
Anupam Singh
Sankaranarayanan Murugesan
Chemistry Central Journal, 9
[29] Synthesis and Biological Evaluation of Novel 2-Arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Zhang, Liang
Tang, Xiaowan
Cao, Yuanyuan
Wu, Shaotong
Zhang, Yu
Zhao, Jianxiong
Guo, Ying
Tian, Chao
Zhang, Zhili
Liu, Junyi
Wang, Xiaowei
MOLECULES, 2014, 19 (06) : 7104 - 7121
[30] De-novo design, synthesis and evaluation of novel 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors
Chander, Subhash
Ashok, Penta
Singh, Anupam
Murugesan, Sankaranarayanan
CHEMISTRY CENTRAL JOURNAL, 2015, 9 : 1 - 13

← 1 2 3 4 5 →